Two new tests to help you standardize your respiratory testing
Results where they are needed, from the lab to the point of care. Take advantage of the benefits of our new respiratory tests. Compatible with Cepheid's GeneXpert® system or GeneXpert® Xpress system.
Speed, plus
Accuracy, plus
Flexibility
That's the PCRplus advantage. From Cepheid.
![]() |
Xpert® Xpress CoV-2 Flu/RSV plus*
|
|
![]() |
Xpert Xpress CoV-2 plus*
|
Easy to learn, adopt, and operate. As simple as 1, 2, 3.
* These tests have not been FDA cleared or approved. These tests have been authorized by FDA under an EUA for use by authorized laboratories. Xpert Xpress CoV-2 plus has been authorized only for the detection of nucleic acids from SARS-CoV-2, and not for any other viruses or pathogens. Xpert Xpress CoV-2/Flu/RSV plus has been authorized only for the simultaneous qualitative detection and differentiation of nucleic acids from SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV), and not for any other viruses or pathogens. The emergency use of these products is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
^ With Early Assay Termination.
# PPA and NPA for asymptomatic specimens were calculated using anterior nasal swab specimens.